Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Solara Active Pharma Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 541540 | NSE: SOLARA

NSE BSE
686.75
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  720.50
  •  724.95
  •  678.25
  •  720.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  255602
  •  1772.75
  •  882.80
  •  303.27

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,301.00
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,114.50
  • N/A
  • 3.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 37.27%
  • 10.09%
  • 18.83%
  • FII
  • DII
  • Others
  • 14.25%
  • 1.28%
  • 18.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -0.50
  • 0.54

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 113.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.90
  • 1.40

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -0.44
  • -8.87

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
-145.25
17.8
32.5
31.4
P/E Ratio
46.26
25.34
26.22
Revenue
1289
1536
1681
1795
EBITDA
-95
276
330
358
Net Income
-567
86
156
151
ROA
-21.6
P/Bk Ratio
3.44
3.36
2.65
2.23
ROE
-46.62
8.1
11.7
9.2
FCFF
-30.66
214.4
220.72
228.42
FCFF Yield
-0.67
4.71
4.85
5.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
346.95
425.24
-18.41%
363.49
352.31
3.17%
299.43
380.62
-21.33%
248.73
394.75
-36.99%
Expenses
285.64
387.61
-26.31%
321.57
333.19
-3.49%
289.67
331.86
-12.71%
410.42
349.75
17.35%
EBITDA
61.31
37.63
62.93%
41.92
19.12
119.25%
9.76
48.76
-79.98%
-161.69
45.00
-
EBIDTM
17.67%
8.85%
11.53%
5.43%
3.26%
12.81%
-65.01%
11.40%
Other Income
0.32
1.18
-72.88%
0.56
2.04
-72.55%
1.70
4.68
-63.68%
0.45
7.17
-93.72%
Interest
28.28
24.44
15.71%
30.87
24.61
25.44%
30.69
21.96
39.75%
25.37
23.64
7.32%
Depreciation
25.34
26.21
-3.32%
25.07
25.91
-3.24%
25.25
26.45
-4.54%
25.96
27.98
-7.22%
PBT
8.01
-17.06
-
-13.46
-29.36
-
-166.66
5.03
-
-275.34
0.55
-
Tax
0.00
0.00
0
0.00
-10.25
-
88.79
1.28
6,836.72%
0.00
0.12
-100.00%
PAT
8.01
-17.06
-
-13.46
-19.11
-
-255.45
3.75
-
-275.34
0.43
-
PATM
2.31%
-4.01%
-3.70%
-5.42%
-85.31%
0.99%
-110.70%
0.11%
EPS
1.99
-4.39
-
-3.35
-5.00
-
-65.37
0.96
-
-70.49
0.12
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
1,258.60
1,288.92
1,443.81
1,268.35
1,616.88
1,321.75
1,408.58
560.41
Net Sales Growth
-18.95%
-10.73%
13.83%
-21.56%
22.33%
-6.16%
151.35%
 
Cost Of Goods Sold
748.96
805.02
788.83
653.89
724.42
598.87
724.03
293.38
Gross Profit
509.64
483.90
654.98
614.46
892.46
722.88
684.55
267.03
GP Margin
40.49%
37.54%
45.36%
48.45%
55.20%
54.69%
48.60%
47.65%
Total Expenditure
1,307.30
1,384.10
1,309.93
1,188.38
1,231.01
1,062.31
1,197.03
500.80
Power & Fuel Cost
-
122.56
108.10
93.70
85.42
77.68
79.35
31.41
% Of Sales
-
9.51%
7.49%
7.39%
5.28%
5.88%
5.63%
5.60%
Employee Cost
-
243.92
228.63
236.34
229.37
204.13
187.82
71.51
% Of Sales
-
18.92%
15.84%
18.63%
14.19%
15.44%
13.33%
12.76%
Manufacturing Exp.
-
109.98
91.64
100.60
95.82
94.74
101.85
48.02
% Of Sales
-
8.53%
6.35%
7.93%
5.93%
7.17%
7.23%
8.57%
General & Admin Exp.
-
41.07
39.43
49.31
47.86
47.70
35.50
15.22
% Of Sales
-
3.19%
2.73%
3.89%
2.96%
3.61%
2.52%
2.72%
Selling & Distn. Exp.
-
34.18
31.68
30.28
31.88
24.70
31.33
17.84
% Of Sales
-
2.65%
2.19%
2.39%
1.97%
1.87%
2.22%
3.18%
Miscellaneous Exp.
-
27.37
21.62
24.26
16.24
14.49
37.15
23.42
% Of Sales
-
2.12%
1.50%
1.91%
1.00%
1.10%
2.64%
4.18%
EBITDA
-48.70
-95.18
133.88
79.97
385.87
259.44
211.55
59.61
EBITDA Margin
-3.87%
-7.38%
9.27%
6.31%
23.87%
19.63%
15.02%
10.64%
Other Income
3.03
5.37
22.55
20.02
28.77
27.52
12.38
2.47
Interest
115.21
105.11
90.06
75.28
84.48
77.89
82.48
25.17
Depreciation
101.62
103.33
111.19
112.32
108.66
94.16
83.70
36.71
PBT
-447.45
-298.25
-44.82
-87.61
221.50
114.91
57.75
0.20
Tax
88.79
78.54
-22.57
-32.81
0.15
0.39
-1.66
-0.14
Tax Rate
-19.84%
-16.08%
50.36%
36.02%
0.07%
0.34%
-2.87%
-70.00%
PAT
-536.24
-567.39
-22.18
-58.15
221.40
114.61
59.51
0.38
PAT before Minority Interest
-536.13
-566.96
-22.25
-58.29
221.35
114.52
59.41
0.34
Minority Interest
0.11
-0.43
0.07
0.14
0.05
0.09
0.10
0.04
PAT Margin
-42.61%
-44.02%
-1.54%
-4.58%
13.69%
8.67%
4.22%
0.07%
PAT Growth
0.00%
-
-
-
93.18%
92.59%
15,560.53%
 
EPS
-111.72
-118.21
-4.62
-12.11
46.13
23.88
12.40
0.08

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
933.91
1,500.21
1,524.87
1,588.53
1,085.94
955.87
763.98
Share Capital
36.00
36.00
36.00
35.93
26.85
25.77
24.67
Total Reserves
896.26
1,463.16
1,487.87
1,548.81
958.36
823.71
739.30
Non-Current Liabilities
171.53
217.14
299.22
206.46
333.31
344.23
315.06
Secured Loans
105.83
235.10
283.04
154.83
232.71
224.97
242.86
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
53.67
49.03
37.07
36.56
32.62
28.79
23.58
Current Liabilities
1,242.79
1,101.13
1,063.42
788.74
729.89
655.50
737.95
Trade Payables
313.01
305.86
275.99
309.29
216.12
244.38
312.87
Other Current Liabilities
167.53
144.38
173.76
116.60
157.28
192.24
90.08
Short Term Borrowings
760.27
648.80
609.90
360.88
353.79
214.47
330.21
Short Term Provisions
1.98
2.09
3.77
1.97
2.70
4.41
4.78
Total Liabilities
2,350.90
2,820.72
2,889.82
2,587.97
2,153.43
1,959.98
1,821.47
Net Block
1,265.50
1,340.02
1,331.80
1,381.58
1,396.94
1,217.80
1,085.93
Gross Block
1,876.36
1,867.65
1,760.45
1,702.15
1,611.23
1,339.37
1,122.64
Accumulated Depreciation
610.86
527.63
428.65
320.57
214.29
121.57
36.71
Non Current Assets
1,550.21
1,633.18
1,650.54
1,530.34
1,481.44
1,311.88
1,213.66
Capital Work in Progress
256.37
238.47
238.65
87.98
40.47
40.37
71.48
Non Current Investment
1.70
1.70
0.42
0.42
0.32
0.41
0.81
Long Term Loans & Adv.
23.77
28.54
54.60
59.19
40.83
36.23
46.40
Other Non Current Assets
0.48
0.51
0.48
1.17
2.88
17.07
9.03
Current Assets
788.07
1,187.54
1,239.28
1,057.63
671.99
648.10
607.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
359.70
558.09
575.55
294.97
279.73
213.94
187.66
Sundry Debtors
348.52
536.99
489.67
483.87
226.53
288.80
262.52
Cash & Bank
8.60
8.89
47.25
198.54
56.78
76.47
47.01
Other Current Assets
71.25
23.22
17.94
72.93
108.95
68.89
110.62
Short Term Loans & Adv.
52.41
60.35
108.87
7.32
69.08
19.76
35.14
Net Current Assets
-454.72
86.41
175.86
268.89
-57.90
-7.40
-130.14
Total Assets
2,338.28
2,820.72
2,889.82
2,587.97
2,153.43
1,959.98
1,821.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
108.87
156.25
-242.03
155.46
242.15
166.33
49.22
PBT
-488.42
-44.82
-91.10
221.50
114.91
57.75
0.20
Adjustment
405.76
186.79
180.96
173.16
168.03
148.26
62.76
Changes in Working Capital
190.63
0.74
-313.79
-205.84
-16.45
-25.29
-10.84
Cash after chg. in Working capital
107.97
142.71
-223.93
188.82
266.49
180.72
52.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.90
13.54
-18.10
-33.36
-24.34
-14.39
-2.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3.51
-81.14
-242.85
-106.30
-358.81
-115.69
-85.47
Net Fixed Assets
-26.61
-107.02
-226.06
-138.36
-272.61
-185.65
Net Investments
1.80
-1.28
3.36
-0.10
0.09
0.41
Others
21.30
27.16
-20.15
32.16
-86.29
69.55
Cash from Financing Activity
-105.65
-112.76
333.57
92.49
96.98
-23.39
67.74
Net Cash Inflow / Outflow
-0.29
-37.65
-151.31
141.65
-19.68
27.25
31.49
Opening Cash & Equivalents
8.73
46.38
197.69
56.04
75.72
45.95
0.00
Closing Cash & Equivalent
8.44
8.73
46.38
197.69
56.04
75.72
45.95

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
238.67
383.80
423.30
441.06
366.93
329.64
309.63
ROA
-21.93%
-0.78%
-2.13%
9.34%
5.57%
3.14%
0.02%
ROE
-46.64%
-1.47%
-3.75%
17.23%
12.48%
7.36%
0.04%
ROCE
-17.29%
1.79%
-0.67%
15.34%
11.73%
9.70%
1.82%
Fixed Asset Turnover
0.69
0.80
0.73
0.98
0.90
1.14
0.50
Receivable days
125.38
129.77
140.08
80.18
71.15
71.43
170.98
Inventory Days
129.95
143.29
125.26
64.87
68.16
52.03
122.23
Payable days
140.30
134.61
163.35
132.36
75.74
84.47
228.45
Cash Conversion Cycle
115.03
138.45
101.99
12.69
63.58
39.00
64.76
Total Debt/Equity
1.07
0.67
0.67
0.38
0.72
0.63
0.83
Interest Cover
-3.65
0.50
-0.21
3.62
2.48
1.70
1.01

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019

News Update:


  • Solara Active Pharma - Quarterly Results
    21st Oct 2024, 14:29 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.